1. Faraji, Abolfazl, Dehghan Manshadi, Hamid Reza, Mobaraki, Maryam, Zare, Mahkameh, Houshmand, Massoud. 2016. Association of ABCB1 and SLC22A16 Gene Polymorphisms with Incidence of Doxorubicin-Induced Febrile Neutropenia: A Survey of Iranian Breast Cancer Patients. In PloS one, 11, e0168519. doi:10.1371/journal.pone.0168519. https://pubmed.ncbi.nlm.nih.gov/28036387/
2. Zhao, Wenhua, Wang, Yongbin, Yue, Xin. 2018. SLC22A16 upregulation is an independent unfavorable prognostic indicator in gastric cancer. In Future oncology (London, England), 14, 2139-2148. doi:10.2217/fon-2018-0207. https://pubmed.ncbi.nlm.nih.gov/29698084/
3. Takeuchi, Akira, Oguri, Tetsuya, Fukuda, Satoshi, Ito, Yutaka, Niimi, Akio. . Variants of SLC22A16 Predict the Efficacy of Platinum Combination Chemotherapy in Advanced Non-small-cell Lung Cancer. In Anticancer research, 40, 4245-4251. doi:10.21873/anticanres.14426. https://pubmed.ncbi.nlm.nih.gov/32727751/
4. Lal, Suman, Wong, Zee Wan, Jada, Srinivasa Rao, Lee, Edmund Jd, Chowbay, Balram. . Novel SLC22A16 polymorphisms and influence on doxorubicin pharmacokinetics in Asian breast cancer patients. In Pharmacogenomics, 8, 567-75. doi:. https://pubmed.ncbi.nlm.nih.gov/17559346/
智鼠故事 
